Canada lags behind other developed countries when it comes to the length of time it takes to approve desperately needed ...

At just 42 years old, Allison Freedman's life took an unexpected and devastating turn. She was a busy mom raising ...

Bispecific antibody therapy is transforming cancer treatment, especially in multiple myeloma, with ongoing studies exploring ...

Don Wright of Stillwater, a retired engineer, lawyer, and father of three, ran his first marathon in 2003, at the age of 61.

Medically reviewed by Marla Anderson, MD Multiple myeloma is a rare type of blood cancer that forms in plasma cells, a white ...

Individualized treatments for cancer show great promise, and three KC-area providers are dialing up their offerings.

Multiple myeloma is a rare, aggressive blood cancer that disproportionately impacts Black men. Despite its increasing ...

Arcellx's anito-cel shows promising efficacy and safety in multiple myeloma. Read why I maintain my hold rating for ACLX ...

Researchers sought to determine whether patients who are functional high-risk had a worse prognosis even without having traditional high-risk features.

The team tackled a critical challenge in treating multiple myeloma-a blood cancer where malignant plasma cells accumulate in bone marrow, leading to debilitating bone lesions in 80% of patients.

In a retrospective study of 315 patients with relapsed/refractory multiple myeloma, retreatment with previously refractory drugs achieved an overall response rate of 56.2% and median progression-free ...

A team of researchers from the Translational Oncology Research Centre (TORC) of Vrije Universiteit Brussel (VUB), in ...